protopic
leo pharma a/s - takrolimus - dermatitt, atopisk - andre dermatologiske preparater - flare treatmentadults and adolescents (16 years of age and above)treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. children (two years of age and above)treatment of moderate to severe atopic dermatitis in children (two years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids. maintenance treatmentmaintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i. forekommer fire ganger eller mer per år) som har hatt et første svar til maksimalt seks uker behandling av to ganger daglig takrolimus salve (lesjoner ryddet, nesten ryddet eller mildt rammet).
durogesic 50 mikrog/ time
janssen-cilag as - fentanyl - depotplaster - 50 mikrog/ time
durogesic 12 mikrog/ time
janssen-cilag as - fentanyl - depotplaster - 12 mikrog/ time
durogesic 25 mikrog/ time
janssen-cilag as - fentanyl - depotplaster - 25 mikrog/ time
durogesic 75 mikrog/ time
janssen-cilag as - fentanyl - depotplaster - 75 mikrog/ time
durogesic 100 mikrog/ time
janssen-cilag as - fentanyl - depotplaster - 100 mikrog/ time
dysport 500 e
institut produits synthèse (ipsen) ab - botulinumtoksin type a - pulver til injeksjonsvæske, oppløsning - 500 e
toctino 30 mg
stiefel laboratories (irland) ltd - alitretinoin - kapsel, myk - 30 mg
toctino 10 mg
stiefel laboratories (irland) ltd - alitretinoin - kapsel, myk - 10 mg
takrolimus accord 0.1 %
accord healthcare b.v. - takrolimusmonohydrat - salve - 0.1 %